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SANSIn response to apoptotic stimuli, the pro-apoptotic protein Bax inserts in the outer mitochondrial membrane,
resulting in the formation of pores and the release of several mitochondrial components, and sealing the cell's
fate. To study the binding of Bax to membranes, we used an in vitro system consisting of 50 nm diameter
liposomes prepared with a lipid composition mimicking that of mitochondrial membranes in which
recombinant puriﬁed full-length Bax was inserted via activation with puriﬁed tBid. We detected the associa-
tion of the protein with the membrane using ﬂuorescence ﬂuctuation methods, and found that it could well
be described by an equilibrium between soluble and membrane-bound Bax and that at a high protein-to-
liposome ratio the binding seemed to saturate at about 15 Bax proteins per 50 nm diameter liposome.
We then obtained structural data for samples in this saturated binding regime using small-angle neutron
scattering under different contrast matching conditions. Utilizing a simple model to ﬁt the neutron data,
we observed that a signiﬁcant amount of the protein mass protrudes above the membrane, in contrast to
the conjecture that all of the membrane-associated Bax states are umbrella-like. Upon protein binding, we
also observed a thinning of the lipid bilayer accompanied by an increase in liposome radius, an effect
reminiscent of the action of antimicrobial peptides on membranes.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Apoptosis is a highly regulated type of programmed cell death
essential to the development and maintenance of tissues and to the
defense of organisms against pathogens [1]. Many of the known
apoptotic pathways involve mitochondrial damage, where permeabili-
zation of the outer mitochondrial membrane results in leakage of a
number of apoptotic factors, including cytochrome c, into the cytoplasm
[2]. This important step just upstream of caspase activation and cell
death is regulated by the Bcl-2 family of proteins [3–5]. Pro-apoptoticated Bid; SANS, small-angle
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lipin; DOPS, dioleoyl phospha-
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d Astronomy, McMaster Uni-
L8S 4M1. Tel.: +1 905 525
in).
l rights reserved.members of this family act to promote the release of apoptotic factors
from the mitochondrial intermembrane space, while anti-apoptotic
members act to inhibit it. For a signiﬁcant number of Bcl-2 family pro-
teins, this function is mediated by a direct interaction with lipid mem-
branes – some family members, such as Bcl-2, Bcl-w and CED-9 are
constitutively bound to membranes, while others signiﬁcantly bind to
membranes only after an activation step, for example cleavage in the
case of Bid, and interaction with cleaved Bid in the case of Bax.
Human Bax is a 22 kDa (192 amino acids) pro-apoptotic Bcl-2 family
member of particular physiological relevance because it can form pores
in mitochondrial membranes [6], and because these pores are thought
to be the functional units that allow for cytochrome c to be releaseddur-
ing apoptosis [7]. In growing cells, Bax ismainly found in the cytoplasm,
but at the onset of apoptosis it migrates to the outer mitochondrial
membrane [8,9] where it undergoes a conformational change [7] and
assembles into oligomers [10,11]. These events coincide with cyto-
chrome c release [7]. In addition, many in vitro studies have shown
that Bax is able to permeabilize lipid membranes [6,12–16]. The pore-
forming activity of full-length Bax can be realized using the C-terminal
fragment of Bid (noted as tBid for truncated Bid), which causes soluble
monomeric Bax to bind to lipid membranes and oligomerize [15–17].
Fig. 1. Schematic representation of two possible pathways for the insertion of Bax into a
lipid membrane. The soluble Bax protein (A) is thought to ﬁrst peripherally associate
with the membrane, or with proteins (i.e. tBid or Bax) already inserted in the membrane
(B). The peripherally associated Bax protein may then insert into the membrane as
follows: (i) it may insert helices 5, 6 and 9 in the lipid bilayer while retaining a globular
conformation above the membrane (mushroom conformation, C); (ii) it may adopt
an open conformationwith all helices roughly parallel to themembrane (D) before insert-
ing helices 5, 6 and 9 in the lipid bilayer (umbrella conformation, E). Interactionswith tBid
and other Baxmolecules, both known to inﬂuence the insertion of Bax into themembrane,
are not represented here.
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conductivity [18], as well as the release of varying size particles
[12,15,19,20] due to the formation of lipidic pores [16,21,22]. In con-
trast, anti-apoptotic Bcl-2 familymembers interactingwithmembranes
(e.g. Bcl-2, Bcl-xL, Bcl-w, CED-9) do not seem to formpores – at least not
large enough to allow for the release of particles such as cytochrome c.
Instead they are thought to inﬂuence apoptosis through protein–protein
interactions [3,5,23].
The soluble form structures of several Bcl-2 family proteins,
including family members which are usually associated with mem-
branesbut becomesolublewhen truncated, havebeen solved, e.g. Bcl-xL
[24], Bcl-2 [25], Bcl-w [26], Bax [27], Bid [28,29] and CED-9 [30]. Inter-
estingly, they all have a three-dimensional structure that is highly
homologous to the soluble form of pore-forming bacterial colicins,
and of diphtheria toxin, with a mainly hydrophobic α-helical hairpin
(also containing charged residues) buried amongst six or seven amphi-
pathicα-helices [31]. The structural homology displayed by these Bcl-2
family proteins, in their soluble form, is intriguing given the fact that
they have diverging functions, namely anti-apoptotic (i.e. Bcl-xL,
Bcl-2, Bcl-w, CED-9) or pro-apoptotic (i.e. Bax, Bid). However, the active
membrane associated conformation of these proteins is still notwell de-
ﬁned. In particular, the conformation(s) adopted by Baxwhen bound to
a membrane is (or are) still unknown.
Even so, there are a few clues available regarding the membrane
conformation(s) of Bax. Firstly, Bax can presumably adopt at least two
conformations when binding to membranes. The clearest evidence of
this is that in healthy cells a small fraction of Bax is found associated
with mitochondria but remains carbonate extractable – corresponding
to an inactive loosely-bound form of Bax, while in apoptotic cells
Bax bound to mitochondrial membranes is no longer carbonate
extractable – corresponding to a pore-forming membrane-inserted
form of Bax [10,32]. Secondly, it is likely that the α-helical secondary
structure of the monomeric soluble protein is conserved when
the protein interacts with lipid membranes [17,33]. Thirdly, the Bax
C-terminus (helix 9) has been identiﬁed as a transmembrane domain,
while in vitro studies of single-point Bax mutants [34–36] and pep-
tide studies [37,38] have implicated helices 5 and 6 in the formation
of pores. It was later conﬁrmed – by chemical labeling of single
cysteine Bax mutants – that all three helices indeed insert in the
outer mitochondrial membrane of apoptotic cells [39]. Finally, the
Bax N-terminus (including helix 1), which interacts with tBid
[7,32,34,35] and contains an epitope (6A7) that becomes accessible
only after activation [40], has been shown to interact with lipid mem-
branes [41,42] and is involved in mitochondrial targeting [34,36]. In
conclusion, while helices 1, 5, 6 and 9 should be in contact with
the membrane in membrane inserted pore-forming Bax, the conﬁgu-
ration adopted by the remaining ﬁve helices is unknown. Moreover,
the conformation(s) adopted by additional membrane bound forms
of Bax, in particular by its predicted loosely-bound form, are un-
known. Fig. 1 illustrates two possible pathways in which soluble
Bax may insert in the membrane. We refer to Bax as being “inserted”
in the membrane if one or several of its helices are transmembrane
(e.g. conformations C and E in Fig. 1), and as being “peripherally
bound” if interacting with the membrane without any transmem-
brane helices (e.g. conformations B and D in Fig. 1). Both “inserted”
and “peripherally bound” Bax are collectively referred to as either
being “bound” or “targeted” to the membrane.
Small-angle neutron scattering (SANS) has proven an ideal tech-
nique for studying the structure of liposomal membranes [43]. It is
also a very promising technique for studying the conformation and qua-
ternary structure of proteins in membranes, as it allows for the detec-
tion of large protein assemblies through the use of contrast variation
experiments [43,44]. For example, SANS has been successfully used to
study membrane oligomers formed by bacteriorhodopsin [44], SecA
[45], and pneumolysin [46]. For this study, we have used a model sys-
tem consisting of full-length recombinant Bax bound to themembranesof 50 nmdiameter liposomeswith a composition approximating that of
mitochondrial membranes, and we have carried contrast variation
SANS experiments to obtain information both on the conformation of
Bax when bound to membranes and on the changes in the membrane
caused by the binding of the protein. To complement the SANS experi-
ments and support our choice of using small liposomes (made so that
higher lipid concentrations and increased signal-to-noise levels could
be achieved), we have carried out complementary ﬂuorescence experi-
ments in order to quantify the membrane binding and pore-formation
activity of Bax in our model system.
2. Materials and methods
2.1. Liposome preparation
Liposomes were prepared from a mixture of lipids that reﬂects the
overall lipid composition of Xenopus mitochondrial membranes, and
which has been shown to support pore formation by tBid-activated
Bax [15,17], i.e. phosphatidylcholine (PC), phosphatidylethanolamine
(PE), phosphatidylinositol (PI), phosphatidylserine (PS) and cardiolipin
(CL), with amass ratio of 48:28:10:10:4. All lipids were purchased from
Avanti Polar Lipids (Alabaster, AL, USA) either as puriﬁed from egg (PC,
PE) or bovine liver (PI), or as synthetic lipids in the case of dioleoyl PS
(DOPS) and tetraoleoyl CL (TOCL). The lipids were dissolved in chloro-
form and then mixed in the appropriate mass ratio. For ﬂuorescence
ﬂuctuation experiments 0.008% by mass of the ﬂuorescent dye DiD
(Invitrogen Canada, Burlington, Canada) dissolved in methanol was
added to the lipids. Solvents were then removed by evaporation
under a stream of nitrogen gas, followed by incubation under vacuum
for 2 h. Dry lipid ﬁlms were resuspended in assay buffer (10 mM
HEPES at pH 7, 200 mM KCl, 5 mM MgCl2, 0.2 mM EDTA) to a total
lipid concentration that varied from 0.5 to 40 g/l. The lipid solutions
were then subjected to 10 freeze–thaw cycles and extruded through
the pores of a Nucleopore track-etched polycarbonate membrane
(Nucleopore, San Diego, CA, USA). Mostly, membranes with 50 nm
pores were used, except for a few experiments when membranes
with larger pores (100 nmor 200 nm)were used. Although the extrud-
ed liposomes are not strictly speaking monodisperse, they do follow a
monomodal size distribution with a narrow polydispersity that effec-
tively constitute a homogeneous sample (i.e. spherical unilamellar li-
posomes). The assay buffer was prepared with the appropriate
fraction of H2O and D2O (Cambridge Isotopes, Andover, MA). HEPES
was from BioShop Canada Inc (Burlington, Ontario, Canada), while all
other chemicals were purchased from Sigma-Aldrich (Oakville, Ontario,
Canada). Estimates for lipid concentrations were obtained by assuming
that dry lipid ﬁlms had been completely resuspended, that the extru-
sion step had no effect on lipid concentration, and that the average mo-
lecular weight of the phospholipids was 770 g/mol [47]. Estimates for
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formed unilamellar liposomeswith diameter 2R=50 nm(or 100 nmor
200 nm), and that each phospholipid, on average, occupied a surface
area of 0.75 nm2 [48] (i.e. m≈ 21,000 lipids per 50 nm diameter lipo-
some). In some cases liposome concentrations were also directly mea-
sured by ﬂuorescence as explained in Section 2.5.3.
2.2. Protein puriﬁcation
Recombinant Bax and the C-terminal fragment of cleaved Bid (tBid)
were obtained according to published protocols [27,49]. For both pro-
teins great care was taken to remove all detergent molecules at the
end of the puriﬁcation process. Brieﬂy, recombinant full-length
human Bax (referred to as wild-type Bax – wtBax – in the following)
with no additional amino acid residues was expressed in Escherichia
coli as an intein/chitin binding domain fusion and puriﬁed using a
chitin afﬁnity chromatography column (NewEngland Biolabs Ltd., Pick-
ering, Ontario, Canada). The release of Bax from the column was
achieved by intein self cleavage triggered by the addition of a buffer so-
lution containing 2-mercaptoethanol (100 mM) and the detergent 3-
[(3-Cholamidopropyl)-dimethylammonio]-1-propanesulfonate
(CHAPS, 0.2% w/v), followed by incubation for 48 h. The eluted 22 kDa
protein product was dialyzed in storage buffer (10 mM HEPES, pH 7.4,
100 mM NaCl, 0.2 mM EDTA, 20% glycerol). Using this method the
ﬁnal protein yield was 0.7 g/l, and Bax was estimated to be at least
95% pure based on Coomassie Blue stained SDS-PAGE gels. EGFP-Bax
puriﬁcation was performed following the same protocol as that of
wild-type Bax, with the additional precaution of wrapping the chitin
column in an aluminum foil during the 48 h incubation period (ﬁnal
yield 0.4 g/l). To preserve activity, the protein was only frozen once at
the end of the puriﬁcation process. Single-cysteine Bax mutants were
puriﬁed according to the same protocol and ﬂuorescently labeled with
diethylaminocoumarin (DAC), or nitrobenzofurazan (NBD) as previous-
ly described [50]. Recombinant full-length murine Bid with an N-
terminal hexahistidine tag was expressed in E. coli and puriﬁed using
a nickel-nitrilotriacetic acid-agarose column (Qiagen Inc., Mississauga,
Ontario, Canada). Puriﬁed Bid was then cleaved using caspase 8 (Enzo
Life Sciences, Exeter, UK). The C-terminal protein fragment (tBid) was
separated from the N-terminal fragment, and from residual caspase 8,
using afﬁnity chromatography on a nickel-nitrilotriacetic acid-agarose
column. The elution buffer contained the detergent octyl β-D-glucopyr-
anoside (OG, 1.2% w/v). The eluted 15 kDa protein was concentrated in
10 mM NaPO4 (pH 8.0), 300 mM NaCl, and 10% glycerol using an
Amicon Ultra-15 centrifugal ﬁlter device (Millipore, Billerica, MA,
USA). The ﬁnal protein yield was 1.5 g/l, and tBid was estimated to be
at least 95% pure based on Coomassie Blue stained SDS-PAGE gels.
2.3. Protein targeting assay
Samples containing different concentrations of liposomes and pro-
teins (with a Bax-to-Bid ratio always equal to 5) were prepared in
assay buffer with proteins added last. They were incubated for 2 h at
37 °C to ensure that equilibrium was reached, then brought back to
room temperature. When working with ﬂuorescent liposomes and
EGFP-Bax, protein bindingwas assessed at that point usingﬂuorescence
correlation measurements. Subsequently membrane-bound proteins
were separated from soluble proteins by gel ﬁltration on a 2.5 ml
Sepharose CL-2B column (Amersham Biosciences/GE Healthcare,
Piscataway, NJ, USA). A total of 12 fractions (0.25 ml each) were collect-
ed. The protein concentration in each fraction was then assessed either
by immunoblotting or again by ﬂuorescence.
2.4. Immunoblotting
Fractions obtained after size-exclusion chromatography were run
on SDS-PAGE gels. Proteins were detected by Western-Blot using themonoclonal Bax antibody 2D2 (a generous gift from Richard Youle) at
a dilution of 1:10,000 [51], or the monoclonal tBid antibody 5C8 (Exal-
pha Biologicals, Shirley, MA, USA) at a dilution of 1:4000. A secondary
antibody conjugated to horseradish peroxidase (Jackson ImmunoRe-
search Laboratories, West Grove, PA, USA) was used at a dilution of
1:10,000. Scanned immunoblots were analyzed using ImageJ [52]. The
intensity of each fraction was evaluated from the image by converting
the scanned blot to an 8-bit greyscale image, inverting the color, and
subtracting the background intensity of the gel around each band.
Membrane binding was quantiﬁed by comparing the summed intensi-
ties of membrane-bound fractions (fractions 1–5) with the total inten-
sity from all protein fractions. A titration blot showed that in the range
of Bax concentrations found in the different fractions collected after the
column (~1 to ~50 nM), therewas indeed a linear relationship between
the amount of Bax present in a fraction and the signal detected (data not
shown).
2.5. Fluorescence ﬂuctuations experiments
2.5.1. Measurements
For ﬂuorescence measurements samples were transferred to a 96-
well microplate with a coverslip bottom (Whatman, Piscataway, NJ).
Time-resolved ﬂuorescence data was acquired and the corresponding
autocorrelation function and photon counting histogramwere comput-
ed using an Insight Research Spectrometer (Evotec Technologies, Ham-
burg, Germany) [53]. The ﬂuorescence of EGFP-Bax and that of DiD-
labeled liposomes was excited using continuous-wave laser diodes
emitting at 488 nm and 635 nm, respectively, and collected in the
“green” protein channel and the “red” liposome channel sequentially
to avoid bleed-through between the two channels. The diameter of
the excitation beamswas set to be smaller than the objective back aper-
ture, resulting in effective detection volume radii of 550 nm (green
channel) and 680 nm (red channel), i.e. signiﬁcantly larger than the li-
posomes that could then be considered as point particles during the
analysis. The excitation power was 25 μW in each channel. This corre-
sponds to a lightﬂux of 2.6 kW/cm2 at the sample for the green channel.
In these conditions, the average time required to photobleach an EGFP
ﬂuorophore residing in the confocal detection volume is estimated to
be 220 ms [54], i.e. signiﬁcantly longer than the residence time of the li-
posome in the detection volume. For ﬂuorescence intensity distribution
analysis (FIDA) measurements, circular beam scanning with 45 μm ra-
dius and 20 Hz frequencywas used to reducephotobleaching [53].Mea-
surements usually consisted of 4 individual 5 s runs. All measurements
were performed at room temperature.
2.5.2. FCS analysis
The autocorrelation functions obtained for samples containing both
EGFP-Bax and liposomes were analyzed (using the Acapella software,
Evotec Technologies) assuming the presence of two independently dif-
fusing ﬂuorescent species, unbound EGFP-Bax and liposomes with
bound EGFP-Bax. For this analysis, the diffusion time (i.e. average resi-
dence time in the confocal detection area) of unbound EGFP-Bax,
τD,1 ~0.5 ms, was ﬁxed to that of the soluble monomeric protein
obtained on the same day in a calibration step. The diffusion time of
the liposomes, τD,2, was left to vary and usually found to be between 5
and 20 ms. This analysis allowed for the retrieval of amplitudes A1 and
A2, which correspond to the terms in the autocorrelation function asso-
ciated to the diffusion of unbound EGFP-Bax and liposomes with bound
EGFP-Bax, respectively. These amplitudes are related to the fraction, f,
and the molecular brightness (i.e. average number of photons detected
per second per particle), Q, of each species, according to Ai= fiQi2 /
(f1Q12+ f2Q22) [55]. An approximate value for the fraction of bound
EGFP-Bax was then obtained using:
f FCSbound ¼ A2: ð1Þ
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fraction of bound EGFP-Bax when Q2=Q1, (in which case A2= f2),
that is when there is one or less Bax molecule bound to each liposome,
but it leads to an overestimate of the bound protein fraction when
Q2>Q1 (in which case A2> f2).
2.5.3. FIDA
The photon counting histograms obtained from the ﬂuorescence
data were analyzed by FIDA using the Acapella software. FIDA returns
the molecular brightness, Q, and the average number of ﬂurophores in
the detection volume, N, and can do so for different ﬂuorescent species,
as long as their molecular brightness is different [56]. As for FCS, the
data collected in the “green” protein channel in the presence of both
Bax-EGFP and liposomes was analyzed assuming the presence of two
different species: unbound EGFP-Bax (with concentration N1green and
with a molecular brightness, Q1green, ﬁxed to that of soluble monomeric
EGFP-Bax, i.e. Q1green ~8 kHz) and liposomes with bound EGFP-Bax
(with concentration N2green and a molecular brightness, Q2green, left to
vary, but always found to be larger than Q1green). The average num-
ber of EGFP-Bax molecules per liposome that carried at least one
EGFP-Bax was then calculated as n=Q2green /Q1green, and the total
EGFP-Bax concentration in the sample by Ngreen=N1green+nN2green.
An estimate for the fraction of bound EGFP-Bax was obtained as:
f
FIDA
bound
¼
Ngreen2
Q
2 green
.
Q
1green
Ngreen1 þ Ngreen2 Q2 green
.
Q
1green
: ð2Þ
This calculation returns an exact value of the fraction of bound
EGFP-Bax when Q2>Q1, i.e. when there is on average more than one
EGFP-Bax bound to each liposome. When Q2=Q1 (i.e. when there is
one EGFP-Bax or less bound, on average, to each liposome), FIDA cannot
distinguish between bound and unbound EGFP-Bax, and leads to an
underestimate of the fraction of bound EGFP-Bax.
The photon counting histograms associated with the data collected
in the “red” liposome channel were also analyzed by FIDA and used to
ﬁnd the exact concentration of liposomes in each sample, Nred – during
this analysis, the molecular brightness of a single liposomewas ﬁxed to
the value Qred determined in a calibration sample containing only lipo-
somes. From there, the fraction of liposomes carrying EGFP-Bax mole-
cules could be calculated (F=N2
green/Nred) along with the exact
Bax-to-liposome ratio (rmeasured=Ngreen /Nred). The value of r obtained
in this way always represents a very accurate and robust measurement
of the Bax-to-liposome ratio – because it is essentially based on the av-
erage values of the ﬂuorescence signal in the green and red channels.
Actual protein and liposome concentrations, c, were obtained from
Ngreen and Nred, respectively, using c=NV0, where the value of the con-
focal volume is V0=10 ﬂ (obtained by performing calibration experi-
ments with ﬂuorescent dyes).
2.5.4. Simple model for Bax binding to liposomal membranes
The observed binding of Bax to liposomal membranes was com-
pared to the predictions of a basic binding model, where one assumes
a partition of Bax between the solution and the membranes according
to the simple equilibrium: Pbound=KLPfree [57]. K is the molar parti-
tion coefﬁcient or apparent association constant between protein
and lipid, L is the lipid concentration, and Pbound and Pfree are the con-
centrations of bound and unbound Bax proteins, respectively. The
fraction of bound Bax then depends on the Bax-to-lipid ratio, P /L,
according to:
f bound ¼
KP
KP þ P=Lð Þ ¼
KL
1þ KL ; ð3Þ
where P is the total Bax concentration.The ratio of bound Bax protein to liposome can then be calculated as
m(P/L)fbound, wherem is the number of lipids per liposome. At high P/L
at least, a random distribution of Bax on the liposomes can be expected.
In this case the fraction of liposomes carrying at least one Bax, f Lbound,
and the average number of Bax bound per liposome carrying at least
one Bax, n, both quantities that can be measured by FIDA as explained
above, can be calculated as:
f Lbound ¼ 1−e−
mKP
1þKL ð4Þ
and
n ¼ mKP= 1þ KLð Þ
1−e−mKP= 1þKLð Þ
: ð5Þ
As long as L≪1/K, n tends towards the limit valuemKP/(1−e−mKP)
at high P/L. On the other hand, if L≫1/K, then n tends towardsmP/L=r
at high P/L.
2.6. Bax oligomerization assay
Bax oligomerization in the membrane of liposomes was assessed by
detecting the ﬂuorescence resonance energy transfer (FRET) between a
single cysteine mutant of Bax (Bax134C) labeled with DAC and a single
cysteine mutant of Bax (Bax126C) labeled with NBD, as described pre-
viously [50]. Brieﬂy, liposomes were incubated with DAC-134-Bax
(donor), NBD-126-Bax (acceptor) in excess and tBid (with a 1 to 5
tBid to Bax ratio). The background ﬂuorescence, FB, was ﬁrst measured
in the absence of the proteins, then proteins were added and the ﬂuo-
rescence of the donor, F(t), was monitored as a function of time
(λex=383 nm, λem=463 nm) using a microplate reader (M1000,
Tecan, Durham, NC, USA). The reduction in ﬂuorescence due to FRET
was assessed by considering the normalized donor ﬂuorescence: (F(t)
−FB)/(F(0)−FB). In each case control experiments were performed
using solutions without liposomes and solutions where NBD-126-Bax
was replaced with unlabeled Bax (i.e. without acceptor).
2.7. Membrane permeabilization assay
2.7.1. ANTS release assay
The capacity of the puriﬁed proteins to permeabilize membranes
was tested using an ANTS release assay, where the dequenching of the
ﬂuorophore 8-aminonaphthalene 1,3,6-trisulfonic acid (ANTS) is
monitored as it is released from the liposomes, which also contain the
quencher p-xylene-bis-pyridinium (DPX) [17]. The ANTS/DPX
liposomes were prepared by supplementing the buffer used to resus-
pend lipid ﬁlms with 12.5 mM ANTS and 45 mM DPX (both purchased
from Molecular Probes, Eugene, OR, USA), and then removing the
non-encapsulated ANTS and DPX by gel ﬁltration over a CL2B-
Sepharose column (Amersham Biosciences, Piscataway, NJ, USA).
When required in order to precisely quantify liposome concentration,
DiD was added to the lipids as explained above. The ANTS ﬂuorescence
emission (λex=355 nm, λem=530 nm) from solutions containing dif-
ferent amounts of liposomes and recombinant proteins was monitored
using an Envision spectroﬂuorometer (Perkin Elmer, Waltham, MA,
USA). Samples with varying lipid concentrations were prepared using
a ﬁxed amount (50 μM lipid) of ANTS/DPX liposomes and varying
amounts of liposomes without ANTS or DPX, in assay buffer. For each
sample the average background ﬂuorescence (F0) was ﬁrst measured
for 30 min in the absence of proteins. Recombinant proteins (i.e. Bax
and tBid) were then added at the appropriate concentration, and the
ANTS ﬂuorescence, F(t), was monitored. After 2 h, Triton X-100 was
added to a ﬁnal concentration of 0.2% – to promote liposome lysis – and
the average maximum ﬂuorescence (F100) was measured over a period
of 10 min. The percentage release of ANTS/DPX was calculated as
R(t)=[(F(t)−F0)/(F100−F0)−(F′(t)−F′0)/(F′100−F′0)]×100, where
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performed at room temperature.
2.7.2. Determination of the Bax binding equilibrium constant from ANTS
release data
To determine the equilibrium constant for Bax binding to liposomes,
K, we followed the approach described by Grant et al. [58]. For a simple
partition equilibrium, Pbound=KLPfree, the conservation equation for Bax
can bewritten P=Pbound(1+1/KL). A particular amount of permeabili-
zation (deﬁned here as a particular amount of ANTS release in the long
time limit, Ri) can be expected to be achieved for a particular number
of bound Bax proteins per liposome, ni, that is for a particular value of
Pbound/L=ni /m. Therefore the Bax concentration necessary to obtain a
given Ri is P(L)=nim(1/K+L).
The values of R (i.e. the percentage of ANTS release after 2 h)
obtained experimentally at a given lipid concentration for different
Bax concentrations were ﬁtted with a simple exponential function:
R Pð Þ ¼ Rmax 1−e−P=P
 Lð Þ 
; ð6Þ
where Rmax is the maximum release obtained in the assay. A speciﬁc Ri
can be obtained by using any combination of P and L that
obeys: P=ln[Rmax/(Rmax−Ri)]P*(L). By identiﬁcation with the
Bax conservation equation obtained above, in the case of a simple par-
tition equilibrium we thus expect P*(L) to depend linearly on L: P*(L)
=a+bL, with K=b/a and si=b ln[Rmax /(Rmax−Ri)].
2.8. Small angle neutron scattering
2.8.1. Experiments
SANS measurements were primarily carried out at the National
Institute of Standards and Technology (NIST, Gaithersburg, MD) 30 m
NG3 SANS instrument [59]. A 12 m sample-to-detector distance (SDD)
was used along with a neutron wavelength λ=8 Å, and λ=5.5 Å for
SDDs of 4 and 1.3 m, resulting in a total range in scattering vector
(q=4π·sin(θ/2)/λ, where θ is the scattering angle) of 0.003
bqb0.5 Å−1. Neutron wavelengths were selected using a mechanical
velocity selectorwith an11% full-width-at-half-maximum(FWHM) en-
ergy dispersion. Samples containing lipids and proteins were prepared
in assay buffer with the appropriate amount of D2O, and incubated at
room temperature for 1 h. Samples were then placed in standard
2 mm-path-length quartz cells. Data were collected using a
640 mm×640 mm 2D 3He position-sensitive detector with a
5 mm×5 mm resolution. Acquired images were corrected using a
suite of software supplied by NIST [60]. Additional measurements
were carried out at Oak Ridge National Laboratory (ORNL, Oak Ridge,
TN) using the Bio-SANS instrument that is located at the ORNL High-
Flux Isotope Reactor (HFIR). A neutron wavelength λ=6 Å with a
14.5% FWHM energy dispersion was used together with SDDs of
2.5 m and 15.3 m.
In the case of lipid dispersions, the scattering from water makes a
substantial contribution to the total scattered intensity and must be
subtracted. Every data set was normalized using the measured trans-
mission, T, deﬁned as the ratio of the direct beam passing through the
sample cell containing either lipids and proteins dispersed in buffer,
IS+W(0), or only buffer, IW(0), to the direct beam passing through an
empty sample cell, IB(0), i.e., TS+W= IS+W(0)/ IB(0). The scattering
from the sample itself was then calculated on an arbitrary scale as
IS(q)= IS+W(q)/TS+W− IW(q)/TW.
2.8.2. Analysis of scattering data
SANS data were analyzed using either a one-strip or a two-strip
asymmetric model based on the multi-strip models developed by
Kučerka et al. [61]. Liposome polydispersity was taken into account by
convoluting the model with the Schulz distribution function [62]. Weassume a nonspeciﬁc association of liposomes, which predicts an
almost unitary interparticle structure factor. This has been conﬁrmed
experimentally for neutral unilamellar liposomes at total lipid concen-
trations b3 wt.% [63]. In the case of the one-strip model, each liposome
is represented by a spherical shell of thickness t and radius R (measured
from the center of the strip), with constant scattering length density
(SLD). In the case of pure liposomes, the shell represents the hydropho-
bic part of the bilayer, while in the case of liposomes with proteins ei-
ther at the protein contrast match point or at the lipid contrast match
point, the shell represents the hydrophobic part of the lipid bilayer, or
the protein layer, respectively. In the case of the asymmetric two-strip
model, each liposome is represented by two concentric spherical strips
with constant SLDs. The inner strip represents the lipid bilayer, eventu-
ally containing proteins, while the outer strip represents the protein
protruding beyond the lipid bilayer. The variable parameters in this
model are: liposome radius (R is measured from the center of the
lipid bilayer); lipid thickness (tL) and lipid bilayer SLD (sL); protein
thickness (tP) and SLD (sP) of the protruding protein layer; and lipo-
some polydispersity (s). The error on the retrieved parameters was
calculated from the covariance matrix coefﬁcients multiplied by the
square root of the total chi-square. All ﬁts to the data include the instru-
mental resolution (Δλ/λ=11%), with sample polydispersity having
the most pronounced effect in “smearing” the SANS data. Nevertheless,
under the present experimental conditions and for the systems in ques-
tion, the technique is sensitive to relative changes of a few angstroms.3. Results
3.1. Bax targeting to liposomes saturates at high protein-to-lipid ratios
To evaluate what percentage of Bax molecules binds to liposomes
and establish the functionality of the small (50 nm diameter) bio-
mimetic mitochondrial liposomes used in the SANS experiments
reported below, a series of membrane targeting experiments was
performed. First, different amounts of Bax activated by tBid (with a
Bax-to-tBid ratio kept constant and equal to 5) were incubated with
different liposome concentrations, after which liposome bound pro-
teins were separated from free proteins by gel ﬁltration and detected
using immunoblotting. Liposomes consistently eluted in earlier
fractions (fractions 2 to 5), as shown by using ﬂuorescent and by
measuring the ﬂuorescence signal in each fraction (Fig. 2A). In con-
trast, free Bax proteins (in the absence of liposomes) consistently
eluted in later fractions (6 and above, immunoblotting data not
shown). The Western-Blots obtained for one particular series of
targeting experiment are shown in Fig. 2B, where 100 nM wtBax
and 20 nM tBid were incubated with varying amounts of liposomes
in order to obtain a Bax-to-liposome ratio before gel ﬁltration com-
prised between r=1 and r=50 (an estimated value of r based on
the total lipid and protein amounts used to prepare the samples).
Strikingly, while at low Bax-to-liposome ratios the majority of Bax
protein was found in fractions 2 to 5 (i.e. bound to liposomes), as
r was increased, an increasing fraction of Bax appeared in fractions 6
and above (i.e. not bound to liposomes). This was observed both at
low (Fig. 2, Bax concentration 100 nM) and at high protein concentra-
tions (Table 1, Bax concentration 10–30 μM, i.e. similar to that used in
the neutron scattering experiments described below). In contrast, im-
munoblotting against tBid showed that for all proteins-to-liposome ra-
tios explored, about 90% of tBid was associated with the membrane
(data not shown). The fact that Bax binding to liposomal membranes
saturated at high rwas a robust feature observed in all of themembrane
targeting experiments performed. However, the fraction of bound Bax
estimated from the immunoblots for a given r varied considerably
from experiment-to-experiment (e.g. between 50 and 80% at r ~1, and
between 0 and 20% at r ~50), despite efforts to work within the linear
response range of the technique.
Fig. 2. Bax targeting to liposomal membranes. Western-Blot and ﬂuorescence analysis of
the different fractions obtained after gel-ﬁltration of samples containing wtBax or EGFP-
Bax incubated with liposomes in the presence or in the absence of the activating protein
tBid. (A) Elution proﬁle of the liposomes (ﬂuorescently labeled with DiD) as obtained
from the recordedﬂuorescence signal in each fraction (average±stdev, n=5). (B) Repre-
sentative elution proﬁle of Bax in the presence of tBid at different Bax-to-liposome ratios
obtained by Western-Blot (wtBax concentration: 100 nM, tBid concentration: 20 nM).
(C) Comparison between the binding of wtBax and EGFP-Bax, as observed by Western-
Blot. (D) Distribution of residence times observed for liposomes carrying EGFP-Bax
shown for one representative FCS experiment. (E) Percentage of Bax bound to liposomes
versus r, as measured by Western-Blot, FCS and FIDA (EGFP-Bax: 100 nM, tBid: 20 nM).
Only one representative series of measurements is shown (for ﬂuorescence measure-
ments: average±stdev, n=10). (F) Comparison of Bax binding in the presence and
absence of tBid, as measured by FCS (EGFP-Bax: 100 nM, tBid, when present: 20 nM).
Only one representative series of measurements is shown (average±stdev, n=10).
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separated by gel ﬁltration. The technique therefore cannot clearly
distinguish between proteins inserted into the membrane and proteins
peripherally bound to the membrane – the latter may or may not un-
bind from the liposomes during gel ﬁltration. In contrast, ﬂuorescence
ﬂuctuation methods, which are performed directly in solution, detect
all membrane-bound proteins whether inserted or peripherally bound
(just as the SANS experiments described below). We therefore used
both ﬂuorescence correlation spectroscopy (FCS) and ﬂuorescenceintensity distribution analysis (FIDA) to further characterize Bax target-
ing to liposomal membranes. For this, EGFP-Bax was used instead of
wtBax, allowing us to detect the protein via its ﬂuorescence emission
– immunoblotting experiments showed that the membrane targeting
of EGFP-Bax is indistinguishable from that of wtBax (Fig. 2C), while
ANTS release experiments showed that the pore-forming activity of
EGFP-Bax is only slightly lower than that of wtBax (see Section 3.5
below).With FCS the distinction between bound and unbound proteins
is made based on diffusion properties (i.e. proteins bound to liposomes
have a diffusion constant more than 10-fold lower – and therefore a
residence time in the confocal detection volume more than 10-fold
higher – than free proteins, see Fig. 2D).With FIDA the same distinction
is made based on speciﬁc brightness, i.e. on the number of photons per
second emitted by a diffusing particle (unbound EGFP-Bax proteins
have a speciﬁc brightness exactly equal to that of a single EGFP ﬂuoro-
phore, while liposomes with bound EGFP-Bax proteins have a speciﬁc
brightness equal to or greater than that of a single EGFP ﬂuorophore,
depending on the number of EGFP-Bax bound to the liposome). For
both ﬂuorescence methods, the fraction of bound Bax was calculated
in a simple but approximate way, where the value fboundFCS calculated
from FCS analysis (Eq. (1)) is correct only at low r, and is an overesti-
mate at high r, while the value fboundFIDA calculated from FIDA (Eq. (2)) is
correct only at high r and is an underestimate at low r (see Materials
and methods for more details). For a typical series of targeting experi-
ments the fraction of bound Bax, as estimated with each of these
three methods (immunoblotting, FCS and FIDA), is shown in Fig. 2E.
As expected, while both FCS and FIDA show the same decreasing
trend as observed with immunoblotting, the FCS estimates are close to
the immunoblotting results only at low r (and always higher), while
the FIDA estimates are close to the immunoblotting results only at
high r (and always lower). In the case of a random distribution of the
proteins on the liposomes, one should be able to calculate the exact per-
centage of bound protein from either the FCS or the FIDA data [64].
However, it has been shown that Bax oligomerization is a cooperative
process [12], therefore the assumption of a random distribution of Bax
on the liposome is likely wrong at low protein-to-liposome ratios.
Also, while in theory FCS and FIDA results could be combined to obtain
the correct bound fraction of Bax, in practice this becomes intractable if
there is a large number of ﬂuorescent species in solution with different
brightness, most likely the case here. Importantly, however, even this
simple approximate analysis (Eqs. (1) and (2)) is sufﬁcient to demon-
strate a few important points beyond the saturation effect observed,
as will be shown in the next three sections.3.2. Bax does not bind to liposomal membranes in the absence of tBid
Immunoblotting suggests that in the absence of tBid, less than ~10%
of Bax or EGFP-Bax is stably bound to liposomes (data not shown and
[50]). However, this does not rule out the possibility that some Bax
may transiently bind to membranes in the absence of tBid, an interac-
tion that could be disrupted during gel ﬁltration. Indeed, the presence
of lipid membranes alone can induce a transient Bax conformational
change [17], and in healthy cells a small fraction of Bax is found loosely
associated with mitochondrial membranes (as shown by the fact that
this fraction is carbonate extractable) [10,32]. Because it is so extremely
sensitive to the presence of bound proteins and because it can be used
in the absence of any gel ﬁltration, FCS offers the possibility to test for
the presence of loosely bound proteins interacting transientlywith lipo-
somes – as long as the interaction lasts formore than a fewms, thus vis-
ibly slowing down the diffusion of the interacting proteins. However,
when observing the diffusion of the EGFP-Bax in the presence of lipo-
somes, but in the absence of tBid (Fig. 2F), it appeared that the total
amount of EGFP-Bax associated with the liposomes is always less than
5% (for r>1), or that the interaction is too transient (lasting less than
a few ms) to be detected by FCS.
Table 1
Liposome structural parameters, Bax membrane targeting, and Bax membrane permeabilization capacity measured for the different Bax-to-liposome molar ratios explored by SANS.
Neutron
Contrast
Estimated Bax
concentrationa
Estimated tBid
concentrationa
Estimated lipid
concentrationa
Glycerol
contenta
Estimated
Bax-to-lipid
ratio, P /Lb
Estimated
Bax-to-
liposome
ratio, rb
Membrane
bound
Bax (%)c
Estimated
bound Bax-to-
lipid ratiod
Estimated
bound Bax-to-
liposome ratioe
Membrane
permeabilizationf
Average
liposome radius,
bR> (nm)g
Polydispersity,
s/bR>h
Lipid bilayer
thickness,
tL (nm)g
Protein layer
thickness,
tP (nm)g
0–40% D2O 0 0 5.3–12.7 g/l
6.9–16.5 mM
0% 0 0 0 0 No 23.7±0.2 0.24 3.8±0.1
15, 40 and
60% D2O
0.27 g/l
12 μM
0.037 g/l
2.5 μM
17 g/l
22 mM
7.9% 1:1800 12 54%
38±8%
~60%
1:3300
1:4700
1:3000
6
5
7
~10–15
Yes 27.7±0.2 0.24 3.4±0.1 5.0 (ﬁxed)
15, 40 and
60% D2O
0.27 g/l
12 μM
0.037 g/l
2.5 μM
7.3 g/l
9.5 mM
8.1% 1:800 27 57%
20±2%
~40%
1:1400
1:4000
1:2000
15
5
11
~10–15
Yes 27.0±0.2 0.35 3.4±0.1 5.0 (ﬁxed)
15, 40 and
60% D2O
0.54 g/l
25 μM
0.073 g/l
4.9 μM
7.3 g/l
9.5 mM
15.8% 1:400 54 20%
12±6%
~20%
1:1900
1:3300
1:2000
11
6
11
~10–15
Yes 27.5±0.2 0.28 3.3±0.1 5.0±1.2
a The protein, lipid and glycerol concentrations listed for the last three samples correspond to those in 15% D2O buffer. 40% and 60% D2O samples were prepared by diluting 15% D2O samples, resulting in lower protein and lipid concen-
trations, but the same Bax-to-liposome ratios.
b Bax-to-lipid and Bax-to-liposome ratios were estimated from the amounts of protein and lipid used to prepare the samples, that are listed in columns 1 and 3.
c The percentage of membrane bound Bax was estimated in three ways for each different r: (i) using a gel ﬁltration targeting assay at the same protein, lipid and glycerol concentration as listed in the table for 0% D2O (ﬁrst line); (ii) using a
gel ﬁltration targeting assay at lower protein concentration (100 nM Bax), but the same r as listed in the table (second line); (iii) using the FIDA data shown in Fig. 3A, assuming that the estimated and measured r values were the same
(third line).
d Bound Bax-to-lipid ratios were estimated from the percentages of membrane bound Bax listed in the previous column.
e Bound Bax-to-liposome ratios were estimated from the listed percentages of membrane bound Bax (ﬁrst three lines) or directly from the FIDA data shown in Fig. 3C, assuming that estimated and measured r were the same (fourth line).
f Membrane permeabilization was assessed using ANTS release for samples prepared with the indicated amount of protein, lipid and glycerol (0% D2O).
g Structural parameters were obtained by global ﬁt analysis of different SANS scattering curves recorded at a given Bax-to-liposome ratio, using either the one-strip (r=0) or two-strip model (r=12, 27 and 54).
h s/bR> is the size polydispersity of the liposomes.
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391D. Satsoura et al. / Biochimica et Biophysica Acta 1818 (2012) 384–4013.3. In the presence of excess tBid, Bax binding to liposomes can for themost
part be described in terms of a simple partition between the solution and
the membranes
Fluorescence measurements performed on samples where both a
ﬂuorescent protein (EGFP-Bax) and ﬂuorescently labeled liposomes
(containing a small amount of the lipophilic dye DiD) were used,
allowed for the determination of precise Bax, liposome and lipid
concentrations. This in turn allowed for the calculation of the
exact Bax-to-liposome ratio (noted “measured r” in the following, as
opposed to the “estimated r” calculated from the protein and lipid
masses used to produce the sample that was discussed above). It was
found that the measured r was often higher than the estimated r, with
large variations observed from preparation-to-preparation. This dis-
crepancy was mainly the result of a lipid concentration that was lower
than expected, showing that during the resuspension and extrusion
steps, not unexpectedly a signiﬁcant amount of lipid was not incorpo-
rated into liposomes. This is one reason why different repeats of the
same experiment might give different values for bound Bax, since this
value depends on r, and the actual r can vary from experiment-to-
experiment.
To test for the real dependence of the fraction of bound Bax on r, we
performed a series of experiments where solutions were prepared with
EGFP-Bax and ﬂuorescently labeled liposomes (both with 50 nm and
100 nmdiameters – larger liposomesmight not behave as point objects
in FIDA experiments and were not used), with an estimated r ranging
from 1 to 50 (as previously) and with a Bax-to-tBid ratio of 5 (i.e.
with tBid-to-liposome ratios ranging from 0.2 to 10). After incubation
these solutions were separated into different fractions by gel ﬁltration.
The actual Bax concentration (P) and lipid concentration (L) were mea-
sured by ﬂuorescence for each sample before gel-ﬁltration, and for each
fraction of each sample after gel ﬁltration, allowing to calculate the
exact Bax-to-liposome ratio for each sample, which was found to vary
from r ~1 to r ~100. In parallel, FIDA was used to measure the fraction
of bound Bax in each of these samples before and after gel ﬁltration
(shown as a function of L, r and P/L in Fig. 3A–D), aswell as the percent-
age of liposomes carrying any Bax (Fig. 3E–F), and the average number
of Bax per liposome (Fig. 3G–H).
Focusing ﬁrst on the experiments done with 50 nm diameter
liposomes (Fig. 3A, C, E, G), the following was observed. For all samples
with a Bax-to-liposome ratio 5 or larger before gel ﬁltration (i.e. with an
initial tBid-to-liposome ratio larger than 1), the different fractions col-
lected after the gel ﬁltration column had a percentage of bound Bax
that seemed uniquely dependent on lipid concentration (Fig. 3A), and
generally in good agreement with a simple partition equilibrium
model (Eq. (3)), especially considering that the measured value of the
bound fraction measured by FIDA is only exact at high r (i.e. at low L).
When less than one tBid molecule per liposome was present (initial
rb5), the amount of bound EGFP-Bax still roughly followed a simple
partition equilibrium but with a lower apparent association constant
(K=0.08±0.02 μM−1 for initial r=1, to be compared with K=3.5±
0.4 μM−1 in the presence of excess tBid, as measured for the experi-
ment shown in Fig. 3A).When considering the dependence of Bax bind-
ing on Bax-to-liposome ratio instead of L, we found that within the
spread of the data r was also a good predictor of the amount of bound
Bax (Fig. 3C), of the percentage of liposomes with Bax (Fig. 3E) and of
the number of Bax per liposome (Fig. 3G), where the amount of
bound Bax monotonously decreases as r increases while the amount
of liposomes carrying any Bax progressively increases, in agreement
with what was observed by immunoblotting. Interestingly, the data
obtained before gel ﬁltration is slightly different, with lower amounts
of binding and fewer liposomes carrying any Bax, but with more Bax
molecules per liposome (Fig. 3A, C, E, G). We attribute this to the possi-
bility that there might be an inactive EGFP-Bax fraction that remains on
the column (the amount of protein recovered from the column is never
100%) and that sampleswere only incubated for 2 h before gel ﬁltration,while samples after gel ﬁltration were incubated for longer periods of
time because of the difﬁculty in measuring different fractions quickly.
3.4. Bax binds to liposomes of different sizes
To directly compare the binding of Bax to liposomes of different
sizes, the data obtained for 50 nm and 100 nm liposomes were plotted
together as a function of protein to lipid ratio (Fig. 3B, D, F, H). Both at
the same L and at the same P/L, a slightly higher fraction of Bax binds
to 50 nm liposomes than to 100 nm liposomes. This effect was quanti-
ﬁed by assuming a simple partition equilibrium between soluble and
membrane bound Bax. First the obtained values of fbound (for r>10
since that is the range in which FIDA data are exact) were ﬁtted as a
function of L with Eq. (3), returning an apparent association constant
K=3.0±0.4 μM−1 for 50 nm diameter liposomes and K=1.3±
0.2 μM−1 for 100 nm diameter liposomes (Fig. 3B, considering the
data of two separate experiments). Second, to explain the dependence
of the data on r and P/L, and in particular the observed saturation of
the number of bound Bax per liposome at high r, the obtained values
of fbound (for P/L>10/m, i.e. P/L>0.0005 and 0.00012 for 50 nm and
100 nm diameter liposomes, respectively) were ﬁtted with Eq. (3) as
a function of P/L. Since fbound is expected to depend on P as well as on
P/L, portions of the data for which 0.002 nMbPb0.01 nM and
0.2 nMbPb1 nM were selected, and separate ﬁts were performed for
these two subsets of data, returning separate values for KP. Subsequent-
ly Kwas calculated using the average value of P for each subset of data.
This way, K=2.4∗106 M−1 to 6.3∗106 M−1was obtained for Bax bind-
ing to 50 nm liposomes, and K=0.8∗106 M−1 to 2.9∗106 M−1 for Bax
binding to 100 nm liposomes. The fact that K seems to depend on P in-
dicates that the partition model used to analyze the data only approxi-
mately describes the behavior of the system. Strikingly, however, the
values of K obtained in a given P rangewere always higher for the smal-
ler liposomes. Using these values to predict the percentage of liposomes
carrying bound Bax (Fig. 3F) and the average number of bound Bax per
liposome carrying Bax (Fig. 3H), we found that the agreement with the
FIDA data was poor at low P/L, but reasonable as expected at high P/L.
In particular, the measured association constants could be used to pre-
dict that, at the Bax concentrations found in these samples (mainly
0.01 nMbPb1 nM), the number of bound Bax per liposome should sat-
urate above P/L ~0.001 reaching ~10 for 50 nm liposomes and ~20 for
100 nm liposomes, in fair agreement with the experimental data.
3.5. Bax activated by tBid oligomerizes and permeabilizes the membrane
of liposomes of different sizes in a concentration-dependent manner
To check the membrane permeabilization activity of Bax under the
conditions of the SANS experiments discussed below (i.e. with 50 nm
diameter liposomes at high protein concentrations and high protein-
to-liposome ratios), several control experiments were performed.
First, a Bax-Bax FRET assay was carried out to verify that Bax did oligo-
merize in the membrane of liposomes with small (50 nm) diameter.
Donor Bax (20 nM, labeled with DAC) was incubated with excess
acceptor Bax (100 nM, labeled with NBD) in the presence of tBid
(24 nM) and either 50 nm, 100 nm or 200 nm diameter liposomes.
The liposomalmembraneswere labeledwithDiD, so that it could be en-
sured that the exact same lipid concentration (estimated at 0.055 g/l or
70 μM) was present in all incubations. The donor Bax ﬂuorescence was
found to decrease over time to a roughly similar extent in all cases
(Fig. 4). On the other hand, when the acceptor Bax was replaced with
unlabeled Bax, the donor Bax ﬂuorescence remained constant (Fig. 4,
shown only for 100 nm diameter liposomes). Thus the observed de-
creased donor ﬂuorescence in the presence of acceptor is due to FRET
and faithfully reﬂects Bax oligomerization. This data show that Bax olig-
omerization is as efﬁcient in small 50 nm diameter liposomes as it is in
larger 200 nm liposomes.
Fig. 3. Quantiﬁcation of Bax targeting to liposomalmembranes using FIDA. (A–D) Percentage of bound Bax, (E, F) percentage of liposomes with bound Bax, and (G, H) average number of
Baxmolecules per liposome as a function of: (A, B) themeasured lipid concentration, (C, E, G) themeasured Bax-to-liposome ratio or (D, F, H) themeasured Bax-to-lipid ratio. The values
of L, r and P/Lwere calculated directly from the ﬂuorescence data. In (A, C, E, G), solid symbols correspond to data obtained before gel-ﬁltration, and open symbols to data obtained after
gel ﬁltration for different fractions. The value rinitial appearing on the ﬁgure legend is the value of r before gel ﬁltration, as estimated from the quantities of protein and lipid used to prepare
the samples. Since all sampleswere preparedwith a Bax-to-tBid ratio of 5 and since the entire tBid population binds to liposomes, the number of tBid per liposome can be estimated to be
rinitial/5. In (B, D, F, H), data is shown for 50 nm diameter liposomes (black symbols) and 100 nm diameter liposomes (blue symbols), and circle and square symbols represent different
repeats of the experiments (without distinguishing between different rinitial). In (A, B, D), lines represent ﬁt of the datawith Eq. (3),where the dashed lines areﬁt of all data point forwhich
r>10,while the solid lines areﬁt of only subsets of these samedata points groupedaccording to Bax concentration (0.1 nMbPb0.5 nMand 1 nMbPb5 nM). In (F) and (H), lines represent
expected values according to Eqs. (4) and (5), respectively, using the values of KP obtained from the ﬁt in (C).
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concentrations (0.04 g/l, allowing for low background scattering) for a
larger range of protein-to-liposome ratios (estimated r=8 to 82) and
at high lipid concentrations under the same conditions as the SANS ex-
periments. The experiments carried out at low lipid concentration
(Fig. 5A) show that the amount of ANTS released from the liposome in-
creases with Bax concentration at low protein concentration, but
reaches a maximum value of ~80% ANTS release for ~100 nM Bax, i.e.
r ~40 (the assay likely ends at 80% rather than 100% due to increased
ANTS ﬂuorescence in the micelles formed by the lipids and by thedetergent used to lyse the liposomes). Although a large amount of scat-
teringwas present in the highly concentrated protein and lipid samples,
making it difﬁcult to obtain a quantitative estimate of the percentage of
ANTS release, it appeared that when activated by tBid, Bax exhibited
membrane permeabilization characteristics for all conditions explored
(Table 1), resulting in about 80% of the ANTS to be released for r=54
(Fig. 5B). This result is consistent with those obtained at low lipid con-
centrations. However, at high lipid and protein concentrations, Bax
resulted in some ANTS release even in the absence of tBid. Taken to-
gether, these release experiments show that for 50 nm diameter
Fig. 4. Bax oligomerization. Normalized DAC-134-Bax (donor) ﬂuorescence recorded
when incubating liposomes of different diameters with 20 nM DAC-134-Bax, 100 nM
NBD-126-Bax and 24 nM tBid. In all cases, the estimated P/Lwas 0.0017. The normalized
ﬂuorescence obtained when the acceptor (NBD-126-Bax) was replaced by unlabeled Bax
(i.e. in the absence of acceptor) is also shown for 100 nm diameter liposomes (crosses).
Lines are exponential ﬁt of the data.
Fig. 5. Bax membrane permeabilization activity. Comparison between the percentage of ANT
8 and 82) and (B) at high lipid and protein concentrations (r=54). In each case, the perce
ratio of 5 to 1 (solid symbols), with Bax only (open circles), or with tBid only (open squares
data obtained at low lipid concentration (0.04 g/l or 50 μM, average±stdev, n=3), while th
n=1). The empty circles represent data obtained with DiD-labeled liposomes in one experim
liposomes of different sizes. The ﬁlled circles represent data obtained for EGFP-Bax. (D) Same
function of Bax concentration for different lipid concentrations (50 nm diameter liposomes)
of lipid concentration, as obtained from the ﬁts shown in (E). Line is a linear ﬁt to the data
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a 2 hour incubation most liposomes carry at least one Bax pore, result-
ing in 50% or more ANTS release (Fig. 5C).
Third, the amount of ANTS release obtained for different size
liposomes was compared. We used DiD-labeled liposomes in order to
ensure that, even if reliable absolute values of the lipid concentration
could not be achieved, relative values of r were reliably obtained
(for this the ﬂuorescence of DiD was measured in each sample and
liposome concentrations were adjusted in order to obtain samples
with liposomes of different sizes and the exact same lipid concentra-
tion). We observed that the amount of ANTS release was signiﬁcantly
higher for smaller liposomes at a given r (Fig. 5C), but comparable for
liposomes of all sizes at a given P/L (Fig. 5D). Using 100 nm diameter
liposomes, we also checked that the EGFP-Bax fusion protein used
for the ﬂuorescence ﬂuctuation data presented above was able to
permeabilize membrane (Fig. 5C). Although the amount of ANTS
release obtained for EGFP-Bax at a given r is not as high as for wtBax,
the ﬂuorescence fusion protein is still able to efﬁciently permeabilize
membranes.S release obtained (A) at low lipid and protein concentrations (for different r between
ntage of release is shown when liposomes were incubated with both Bax and tBid in a
). (C) Percentage of ANTS release after 2 h as a function of r. The open crosses represent
e open squares represent data obtained at high lipid concentration (7.3 g/l or 9.5 mM,
ent in order to ensure that relative Bax-to-liposome ratios were exact even when using
data as in (C), plotted as a function of P /L. (E) Percentage of ANTS release after 2 h as a
. Lines represent exponential ﬁt to the data according to Eq. (6). (F) P*(L), as a function
, which gave a=57 nM and b=4.8 nM/μM.
Fig. 6. Neutron scattering of liposomes as a function of % D2O. Scattered intensity as a
function of scattering vector obtained for liposomes with a mitochondria-like lipid com-
position in buffer containing different percentages of D2O (black squares: 5% D2O, red cir-
cles: 10% D2O, green triangles: 15% D2O, inverted dark blue triangles: 20% D2O, light blue
diamonds: 25% D2O, pink sideway triangles: 40% D2O). Gray lines are ﬁts to the data using
the one-strip shell model. Note that the background level increases with the increasing
content of H2O as a result of incoherent scattering from hydrogen. Inset: Square-root
zero angle intensity of the scattering as a function of % D2O.
Fig. 7. Neutron scattering of liposomes with Bax and tBid at 15% D2O. (A) Scattering data
obtained for Bax and tBid incubated with liposomes at the lipid contrast match point
(15% D2O), compared to the data obtained for liposomes alone and buffer alone (also at
15% D2O). (B) Scattering data obtained for soluble monomeric Bax (0.69 g/l or 31 μM)
compared to scattering from the buffer at 0% D2O.
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liposomes at three different lipid concentrations (Fig. 5E) to obtain an
estimate of the equilibrium constant describing Bax binding to the
lipids, following an approach previously used to measure the mem-
brane binding constant of a pore forming peptide [58]. The ANTS release
data wasﬁt assuming an exponential dependence on Bax concentration
(Eq. (6)), providing three different values for the parameter P*, which
showed a linear dependence on L (Fig. 5F), as expected for a simple
equilibrium (see Section 2.7.2 in Materials and methods for details).
This provided an estimate of the apparent binding constant of Bax to
lipid membranes, K=0.084 μM–1. Although this value is at least one
order of magnitude lower than those obtained from the FIDA experi-
ments presented in the previous section, one needs to consider that
this corresponds to an effective Bax binding constant before the sam-
ples have been passed through the size-exclusion column, that is before
any inactive protein is eliminated from the sample (and indeed samples
examined by FIDA before the size-exclusion column showed lower Bax
binding levels).3.6. Contrast matching of mitochondrial-like liposomes
Liposomes used in this studyweremade from amix of lipids (PC, PE,
PI, PS and CL) reﬂecting the lipid composition of mitochondrial mem-
branes. To verify that good neutron contrast matching could be
obtained for these membranes, a series of SANS experiments was per-
formed for liposomes in buffer containing between 5% and 40% D2O,
at a constant lipid concentration of 5.3 g/l. Scattered intensities (I) plot-
ted as a function of scattering vector (q) are shown in Fig. 6. The inten-
sity of the scattering curves, I(0), is related to the square of the contrast
between the average SLD of the lipid membrane, SLDS, and the SLD of
the buffer, SLDW, i.e., IS+W(0)∝(SLDS−SLDW)2 [65]. One then expectsﬃﬃﬃﬃﬃﬃﬃﬃ
I 0ð Þp to be linear as a percent of D2O in the buffer. In determining
I(0), by ﬁtting the scattering curves with the one-strip shell model
and plotting
ﬃﬃﬃﬃﬃﬃﬃﬃ
I 0ð Þp as a function of % D2O (Fig. 6, inset), a linear depen-
dence was observed with a contrast match point at 15% D2O.3.7. Membrane associated Bax can be detected by SANS
SANS data for Bax incubated with liposomes and activated by tBid
was recorded in 15% D2O buffer (that is at the lipid membrane contrast
match point, when only scattering from the proteins should be
recorded) at high Bax-to-liposome ratios (estimated r=12, 27 and 54,
obtained using protein and lipid concentrations as listed in Table 1),
that is in the limit where binding of Bax to the liposomes is saturated.
The corresponding scattered neutron intensities are shown in Fig. 7A,
where they are compared to SANS scattering curves obtained from lipo-
somes in the absence of protein (r=0, lipid concentration of 7.33 g/l).
As expected, no scattering was observed for the sample containing
only lipids (r=0), since 15% D2O corresponds to the membrane con-
trast match point. On the other hand, a clear scattering signal was
observed when proteins were present, and this was true for all Bax-
to-liposome ratios explored. To check whether part of this signal
might correspond to scattering as a result of untargeted monomeric
Bax in solution, the scattering by soluble monomeric Bax (in the
absence of liposomes) was measured in 0% D2O (Fig. 7B). The contrast
between protein and buffer is larger at 0% D2O than at 15% D2O, and
the Bax concentration used in this control experiment (0.69 g/l) was
higher than the total Bax plus tBid protein concentration in either of
the membrane-inserted Bax samples studied (which varied between
0.31 and 0.61 g/l, see Table 1). Despite this, no scattering was observed
showing that soluble monomeric Bax does not signiﬁcantly scatter
Fig. 8. Neutron scattering of liposomeswith Bax and tBid for different contrast conditions.
(A) Scattering curves obtained for a Bax-to-liposome ratio r=54 under different contrast
conditions. Solid lines are ﬁts to the data using the asymmetrical two-strip model. Note
that the background level increases with the increasing content of H2O, because of the in-
coherent scattering from hydrogen. (B) Scattering curves obtained at the protein contrast
match point (40% D2O) for liposomes in the absence of proteins and for three different
Bax-to-liposome ratios. Solid lines are ﬁts to the data using the one-strip model. Arrows
and dotted lines indicate the approximate position of the ﬁrst minimum of the scattering
curves. Curves have been shifted vertically for clarity. (C) Scattering curves obtained at the
protein contrast match point (40% D2O) for liposomes in buffer, liposomes in buffer with
glycerol, and liposomeswith tBid in bufferwith glycerol. Data shown in (C)were obtained
using the ORNL SANS instrument.
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was expected given the small radius of gyration of soluble Bax
(~2 nm), and assuming no long-range correlations between its mono-
mers. Over the q range studied, soluble Baxwould give rise to a constant
incoherent scattering (i.e. background), and the diffuse scattering pro-
duced by individual Bax molecules would not be observed (whereas
we expect to detect scattering from membrane bound Bax species
which reside on the membrane of larger objects – liposomes – and
may also be part of large oligomers). This conclusion also applies to sol-
uble tBid (although no signiﬁcant amount of tBid is expected to be pre-
sent in solution), since tBid has a lower molecularmass than Bax, and is
only present in low concentrations (0.037 to 0.073 g/l). Thus the
scattering signal observed for 15% D2O liposomes containing activated
Bax can only be attributed to proteins bound to liposomes.
3.8. Distribution of Bax on liposomes
In order to better observe the distribution of the proteinwith respect
to the lipid membrane, contrast variation experiments were performed
where the buffer's SLDwas systematically varied. Contrast variation (i.e.
altering the D2O content of the buffer) does not alter the system under
study, but allows rendering parts of this system (e.g. the lipids at 15%
D2O and the proteins at 40% D2O) “invisible” to the neutrons, and thus
obtaining structural information about the rest of the system (e.g. the
proteins at 15% D2O and the lipids at 40% D2O) separately. For each of
the three Bax-to-liposome ratios investigated (estimated r=12, 27,
and 54), as well as for a control sample with liposomes in the absence
of proteins (r=0), SANS data were collected at 15%, 40% and 60%
D2O. The data obtained for r=54 in different buffer conditions is
shown in Fig. 8A (allowing in particular to directly compare the scatter-
ing from the membrane bound proteins, at 15% D2O, and the scattering
from the lipids, at 40%D2O). The data obtained at 40%D2O for all Bax-to-
liposome ratios explored is shown in Fig. 8B (allowing to directly com-
pare the scattering from the lipids in the presence of different amount of
proteins). One striking feature of the data was that for different contrast
conditions scattering curveswere very similar (e.g., Fig. 8A), except that
at 15% D2O the amount of signal was much lower (as expected since at
15% D2O only the few proteins present contribute to the neutron
scattering signal), and the amount of background much higher
(as expected due to increased incoherent scattering from H2O). This
similarity between the different contrast conditions does not mean
that lipids still scatter at 15% D2O (since we have shown in the previous
section that this was not the case), but rather can be understood if one
assumes that there were at least two independent scattering units per
liposome, either protein monomers or protein oligomers.
Two or more protein scattering centers constrained within the sur-
face of the same liposome would result in interferences between neu-
trons scattered by these different proteins, giving rise to intra-
vesicular pair interference terms in the scattering function. Taking
into account the independent relative orientations of these scattering
centers on different liposomes, this translates in the object being best
described by a spherical shell with a radius similar to that of a liposome,
as illustrated in Fig. 9. In this case, the scattering data obtained from the
protein on the liposomes (i.e. the data obtained at 15% D2O) is expected
to resemble the scattering data obtained from the liposomes them-
selves (i.e. the data obtained at 40% D2O). Consequently, the scattering
curves obtained in the presence and in the absence of protein were an-
alyzed using either the one-strip or the asymmetric two-strip model, as
described in the Materials and methods section. First, the three scatter-
ing curves obtained at a given contrast matching condition for all three
samples with proteins (r=12, 27 and 54) were considered as an
ensemble. At 40% D2O (the contrast match point of the protein), both
the individual and global analysis of the data with the one-strip model
indicated that the hydrophobic part of the lipid bilayer formed a shell
with an average radius of 28.1±0.1 nm and a thickness of 3.2±
0.1 nm, i.e., the inner radius of the liposome is ~26 nm and the outer
Fig. 9. Schematic of the neutron contrast variation experiment. For a liposomewith Bax inserted in its membrane (top row, with Bax represented in a variety of possible conformations),
the diagram represents the principle of the neutron contrast variation experiment (second row), the rotational averaging brought about by SANS (third row), and the result of the global
analysis using the asymmetrical two-strip model (fourth row).
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lipids), both the individual and global data analysis with the same one-
strip model indicated that the thickness of the protein shell was 11±
1 nm, with an average radius of 30.4±0.6 nm, meaning that the pro-
teins were positioned between ~25 nm (inner radius) and 35 nm
(outer radius) from the center of the liposome. From this simple analy-
sis, it is evident that the protein forms a signiﬁcantly thicker layer than
the lipid bilayer, with most of the protein mass protruding beyond the
lipids, on the outside of the liposomes.
A slightlymore reﬁned approach consisted in performing a global ﬁt
to the scattering data obtained for a given Bax-to-liposome ratio
at different contrast match points, allowing for the use of the asymmet-
ric two-strip model. Results from this analysis are summarized in
Table 1. At all Bax-to-liposome ratios explored, the picture wasessentially the same as that from the simple one-strip model. The
radius of the liposomes was on average R ~27.5 nm, the hydrophobic
part of the lipid bilayer had a thickness tL of ~3.3 nm, and the protein
layer residing above the lipid bilayer had a thickness tP of ~5 nm. This
last featurewas present at all protein-to-liposome ratios, however, pro-
tein thicknesswas obtained reliably only at r=54, for which the signal-
to-noise ratio was more favorable than for the other samples. Protein
thickness was then constrained when analyzing the data obtained for
r=27 and r=12 samples.
3.9. Changes to the lipid bilayer upon interaction with tBid-activated Bax
An interesting aspect of the interaction between a protein and a lipid
membrane is the inﬂuence that the protein will have on lipid
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paring the scattering curves obtained at the protein contrast matching
point (40% D2O), in the presence and in the absence of protein
(Fig. 8B). Analyzing these data with the one-strip model, where the
strip represents the hydrophobic part of the lipid bilayer, allows one
to determine how the presence of the proteins inﬂuences the radius
and thickness of the lipid shell. In the presence of tBid-activated Bax
proteins, two very clear effects were observed. First, the radius of the li-
posomes increased by about 18%, from 23.7 nm in the absence of pro-
tein to ~28 nm in the presence of Bax with no visible dependence on
the amount of Bax for r=12 to 54 (in Fig. 8B this increase is reﬂected
in the shift of the ﬁrst minimum of the scattering curves towards
lower q in the presence of protein). This radius increase corresponds
to a ~40% increase in the liposome's surface area, i.e. the surface of
each liposome increased by ~2800 nm2. Second, the membrane's hy-
drophobic thickness decreased by ~11%, from 3.8 nm in the absence of
protein to ~3.4 nm in the presence of protein, again with very little de-
pendence on the Bax-to-liposome ratio under the conditions explored
here. These results are in agreementwith those obtained from the glob-
al ﬁt of the data obtained at different D2O concentrations using the two-
strip model (Table 1). In particular, the increase in liposome radius is a
robust observation, and although liposomes used in the different SANS
experiments came from several different batches, liposome radius was
very reproducible from one batch to another.
In a separate series of SANS experiments, it was veriﬁed that the ob-
served membrane thinning was not due to the action of tBid or to the
presence of glycerol (since in the samples used for the SANS
experiments used above, the presence of Bax was correlated with that
of glycerol, see Table 1). In order to do so, liposomes were incubated
in 40% D2O buffer either 1) on their own, 2) with glycerol alone or 3)
with glycerol and tBid, and SANS scattering curves were recorded. The
lipid concentration (4.8 g/l), glycerol concentration (5.4%) and tBid con-
centration (0.04 g/l) used for these experiments were comparable to
those used in the experiments presented in Fig. 8B (for which the
lipid concentrations were 10.9 g/l, 4.8 g/l and 4.8 g/l, the glycerol con-
centrations were 5.2%, 5.3% and 6% and the tBid concentrations were
0.024 g/l, 0.024 g/l and 0.048 g/l, for r=12, 27 and 54, respectively). Li-
posomes in all three samples came from the same batch. Although the
resolution of these experiments was lower than that obtained in previ-
ous SANS experiments, analysis with the one-strip model convincingly
showed that the radius of the liposomeswas unaffected by the presence
of either glycerol or tBid, remaining at r=22 +/− 0.6 nm for all three
samples measured. Therefore the observed membrane thinning is spe-
ciﬁcally due to the interaction of Bax with the membrane.4. Discussion
4.1. Models for analyzing SANS data
Neutron scattering represents a unique opportunity for the investiga-
tion ofmembrane protein oligomers because of the possibility of studying
the system at the contrast match point of either the lipid or the protein
[44]. Here we used a 50 nm diameter liposomal system, which mimics
themitochondrialmembrane and its interactionswith proteins as argued
below. In describing the system, the data were analyzed using either a
one-strip hollow sphere model (for liposomes alone, or for liposomes
with proteins at either the contrast match point of the protein or the
liposomes) or a two-strip hollow sphere model (for liposomes in the
presence of proteins), which was sufﬁcient to adequately ﬁt the data.
Despite the simplicity of these models, features such as liposome radius,
membrane thickness, and protein thickness are well and robustly
resolved. In addition, the mere fact that the protein signal (i.e. liposomes
with proteins at the contrast match point of the lipids) could be ﬁtted
with the hollow sphere model resulted in important information regard-
ing the protein's distribution on the liposome's surface.4.2. Interaction of Bax with small diameter liposomes at high Bax-to-lipid
ratios
Gel-ﬁltration experiments followed by immunoblotting and
ﬂuorescence experiments conﬁrmed that tBid-activated Bax binds to
50 nm diameter biomimetic mitochondrial membranes, forms oligo-
mers when interacting with them and is able to permeabilize them,
with the amount of permeabilized liposomes becoming signiﬁcant for
Bax-to-liposome ratios larger than ~10. The data collected in this
study show that at a given protein-to-lipid ratio (a quantity whose
relative values could be controlled very precisely using ﬂuorescently
labeled proteins and liposomes), the amount of Bax binding, Bax
oligomerization and Bax-mediated liposome permeabilization were
comparable for 50 nm diameter liposomes, 100 nm liposomes (a size
of liposome often used in in vitro studies of Bcl-2 family proteins
[14,17,50]) and 200 nm liposomes. As a matter of fact, the apparent
association constant measured for Bax binding to 50 nm diameter
liposomes is ~2-fold larger than that measured for 100 nm liposomes
(K=3 μM−1 in the ﬁrst case and K=1.3 μM−1 in the second case).
These observations are in contrast to a previous report that liposomes
smaller than 200 nm in diameter barely support Bax binding and do
not support Bax oligomerization [66]. However, the lipid composition
used in our study, which approximates the lipid composition of
mitochondrial membranes, was different from the lipid composition
used in Ref. [66] (which contained no PS, but instead contained
cholesterol). In addition, the Bax protein used in Ref. [66] still had a
Histidine tag, whereas the Bax proteins used in our study did not. One
should also note that although it has been shown that Bax
permeabilization is enhanced in the presence of lipids with positive
intrinsic curvature such as PS, this does not mean that the curvature
of the lipid bilayer (and therefore the size of the liposomes) inﬂuences
Bax interaction with membranes. Rather, it suggests that the Bax pore
structure is lipidic and that the curvature of the lipid monolayer at the
pore is highly positive [14].
Although Bax binding was discussed here in terms of a simple equi-
librium between soluble Bax and membrane associated Bax, the actual
experimental system obviously has several more layers of complexity:
1/the activation process by tBid – which was rendered inconspicuous
here since tBid was mostly always present in excess – obviously plays
essential role for Bax binding, 2/the distribution of Bax on the liposomes
is not likely to be random at small protein-to-lipid ratios, as it has been
shown that a truncated autoactive version of Baxwas forming pores in a
cooperative manner [12], 3/inactive Bax proteins or Bax proteins bind-
ing to the sample surfaces might displace the equilibrium, and 4/Bax
may have several membrane-bound conformations, as further dis-
cussed below. It is then all the more striking that for a given liposome
size the fraction of bound Bax primarily depends only on protein-to-
lipid ratio. The simple partition model predicts that the percentage of
bound Bax (Eq. (3)) and the number of bound Bax per liposome
(Eq. (5)) should depend on Bax concentration as well as on protein-
to-lipid ratio. Yet, when the binding data shown in Fig. 3B was subdi-
vided according to Bax concentration, only a weak dependence on P
was found, where the value obtained for KP (by ﬁtting the data with
the simple equilibrium model) increased less than 2-fold for a 10-fold
increase in P. This means that membrane binding becomes weaker
when Bax concentration is increased. As a result, the amount of bound
Bax does not strongly depend on Bax concentration. For tBid concentra-
tions higher than ~1 tBid per liposome, neither does it depend on tBid
concentration. Instead the amount of bound Bax (and in particular the
maximum amount of Bax molecules per liposome reached at high Bax
concentration) primarily depends on the Bax-to-liposome ratio. This
suggests that Bax binding is critically regulated by some property
of the lipid membrane, for example lipid composition (i.e. the presence
of a particular lipid receptor), membrane charge, or membrane tension.
It must also to some extent be regulated by membrane curvature, since
as mentioned above the apparent binding constant describing the
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size, however this effect seems weak. Importantly, this weak depen-
dence of binding on Bax concentration explains the saturation of the
number of bound Bax per liposome observed in our system. The parti-
tion models predict that at low liposome concentrations (L≪1/K,
which was the case in the ﬂuorescence experiments presented here)
Bax binding should saturate when L decreases and P/L increases, reach-
ing the limit value n=mKP (Eq. (5)). Given the values estimated for KP
from the measured binding isotherm (Fig. 3B), this indeed corresponds
to a limit value of n ≈ 10 for 50 nm diameter liposomes. It is possible
that this limit value will slightly increase with increasing protein and
lipid concentration, and it therefore constitutes a lower bound for the
number of Bax proteins in high protein and lipid concentrations sam-
ples used here for SANS.
Importantly, all of the observations made highlighted the system's
robustness. The insertion of tBid and Bax into the membrane has been
suggested to result in destabilization of lipid bilayers in vitro [67,68],
and Bax has been observed to participate into mitochondrial remodel-
ing during apoptosis in vivo [69,70]. However, even at high lipid con-
centrations (up to 17 g/l or 22 mM) and high Bax and tBid
concentrations (up to 24.5 μM for Bax and 4.9 μM for tBid), the
average dimension and polydispersity of the liposomes remained con-
stant over periods ofmore than 24 h (the duration of a scattering exper-
iment), an observation consistent with the fact that the size and speciﬁc
brightness of liposomes (as measured by FCS and FIDA) was never ob-
served to change over time in our experiments, whatever the concen-
tration of Bax and tBid added. This shows that destabilization upon
addition of tBid and Bax, if present, does not result in deformation,
breaking up, fusion or aggregation of the liposomes, that is to say the
membrane openings formed by Bax do not perturb the structure of
the liposomes on themacroscopic scale. This is consistentwith previous
observations in which incubation of outer mitochondrial membrane li-
posomes with Bax and cleaved Bid resulted in the release of 2000 kDa
dextran molecules, but with no detectable morphological changes in
the structure of liposomes, as assessed by electron microscopy [15]. In
addition, the fact that the scattering data could be well ﬁt by the asym-
metric two-strip model indicates that the bulk of the protein remained
on the outside surface of the liposomes. In other words, even after 24 h
the proteins have not signiﬁcantly penetrated the liposomalmembrane.
Instead, they have remained bound or inserted in the membrane in the
same orientation as when they were ﬁrst introduced. Thus, although
Bax pore formation induces the exchange of lipids between the two
membrane leaﬂets [21], it does not promote ﬂip-ﬂop of the proteins
themselves, or at least not for a signiﬁcant fraction of the bound
proteins.
In conclusion, all the data collected point to the viability of the pre-
sent model system, which contained high lipid concentrations under
the form of small liposomes and high activated Bax-to-liposome ratios
(r>10), as a mimic for a pore-forming protein in a lipid membrane.
4.3. Membrane conformations of Bax
Whereas the conformation of Bax in membranes remains unknown
– apart from the fact that in its active formhelices 5, 6 and 9 are inserted
into the lipid bilayer – the membrane conformations of anti-apoptotic
Bcl-XL and tBid have been the object of numerous structural investiga-
tions. The results of a solid state NMR study of Bcl-XL inserted in a syn-
thetic membrane were consistent with a model where most of the α-
helices of the protein were arranged parallel to the membrane, while
a few other helices were arranged at some angle from the plane of the
membrane (presumably helices 5 and 6) [71]. This type of “umbrella
conformation” was ﬁrst described for bacterial colicins [72]. In the
case of tBid, NMR [73], spin labeling [74], and Monte Carlo simulations
[75] concur that all six helices are arranged more or less parallel to the
plane of the membrane. This led to the proposition that Bax would
also adopt an “umbrella” conformation with helices 2, 3, 4, 7 and8 arranged parallel to the membrane, and further, that an intermediate
conformation of Bax may be present where all of its helices would lay
parallel to themembrane [41]. However,membrane inserted Bax differs
frommembrane boundBcl-XL and tBid in importantways, namely in its
capacity to oligomerize and to permeabilize membranes.
The SANS data presented in this study unequivocally shows that
for lipidmembranes exposed to tBid-activated Bax, a ~5 nm thick pro-
tein layer is present in places above the lipid bilayer. Analysis of the
data obtained at 15% D2O and 40% D2O using the one-strip model
shows that the protein layer is thicker than the lipid layer, and for
data obtained at 60%D2O the two-stripmodel gives a signiﬁcantly bet-
ter ﬁt than the one-strip model. This emphasizes the importance of
membrane bound Bax conformations for which most of the protein
is protruding above the membrane, and invalidates the possibility
that all membrane conformations of Bax are umbrella-like. According
to our targeting and permeabilization assays, under the conditions ex-
plored in our SANS experiments (estimated r≥12) at least 10 Bax pro-
teins were bound to each liposome (Fig. 3) and at least some of these
proteins were in their pore-forming conformation – since most lipo-
someswere permeabilized (Fig. 5). Therefore, one possible interpreta-
tion of the SANS data is that the protein coat detected corresponds to a
cap formed by Bax pores. An atomic force microscopy study of sup-
ported lipid bilayers hinted at this possibility by showing that in the
presence of Bax, small pores were surrounded by a rim approximately
5 nm high [22]. This could occur if membrane-inserted Bax adopts a
mushroom conformation (e.g. such as conformation C represented in
Fig. 1), or if Bax molecules peripherally bind to either Bax or tBid pro-
teins lining the pores (conformation similar to B in Fig. 1). Mushroom
conformations have been observed for several other pore-forming
proteins, in particular for the staphylococcal toxin α-hemolysin [76].
However, this protein forms stable proteinaceous pores very different
in nature from the variable size lipidic pores formed by Bax [12,16,21].
A second possible interpretation of the data is that the conspicuous
protein layer observed above the membrane corresponds to proteins
peripherally bound to the liposomes (resembling conformation B in
Fig. 1, where the overall soluble structure of the protein is conserved
and no helices are inserted in the membrane). The idea that Bax may
have a peripheral, loosely bound conformation, is consistent with the
observation made in several previous studies that in its non-activated
state Bax weakly and transiently interacts with lipid membranes. First,
in vitro, Bax changes conformation (exposing the 6A7 isotope) in the
sole presence of membranes [17]. Since our own observations show
that in these conditions Bax does not lastingly bind to liposomal mem-
branes, it means that it must transiently interact with them. Second, in
healthy cells a small fraction of Bax is found attached to mitochondria,
yet this fraction is carbonate-extractable, meaning that the interaction
between the Bax molecules and the membrane is weak [10,32]. Finally
a recent study has shown that Bax constantly shuttles from the cyto-
plasm to the mitochondria, showing that this weak interaction is also
transient [77]. Although this weak interaction between Bax and lipid
membranes is short lived in the absence of tBid, it could be that tBid
stabilizes Bax's peripherally bound conformation. If a signiﬁcant
fraction of peripherally bound Bax is present, this conformation is
stable enough that it remains present on the membrane after gel-
ﬁltration – our ﬂuorescence experiment before gel ﬁltration shows the
same percentage of bound Bax as the gel-ﬁltration analysis.
Peripherally bound proteins, even in a monomeric state, would have
contributed to the SANS signal, as they would have been part of a
larger scattering unit (i.e. liposomes with several peripherally bound
proteins). The observed thickness of the protein layer, ~5 nm, is
consistent with the presence of Bax proteins only weakly interacting
with the membrane and adopting a conformation similar to their
solution conformation, since the diameter of soluble Bax is ~4 nm (as
inferred from its NMR structure, PDB ID: 1F16) [27]. The existence of pe-
ripherally bound Bax in a compact conformation, such as conformation
B in Fig. 1, is also supported by Monte Carlo simulations [78]. Although
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Bax conformation in the SANS data, such a conformation (e.g. an
umbrella-like conformation such as conformation E in Fig. 1) would be
very difﬁcult to detect in the presence of a more conspicuous peripheral
compact conformation. Thus the fact that it was not observed does not
mean that it does not exist.
If indeed Bax adopts several different conformations at the
membrane, as suggested in this second scenario, then the binding
isotherm shown in Fig. 3B suggests that all these conformations are in
equilibrium, and are also in equilibrium with soluble Bax. Therefore
the transition between loosely bound and membrane-inserted Bax
must be reversible, and the pores must have a transient rather than
stable structure. The idea that different Bax states are in equilibrium is
supported by several previous observations, in particular the
observation that the Bax-Bax interactions in Bax oligomers can be
displaced by new Bax [50], and the observation that Bax constantly
shuttles from cytoplasm to membrane in healthy cells [77]. Likely, the
relative amount of different Bax conformations is inﬂuenced by a num-
ber of parameters. In particular, it is conceivable that the prominence of
peripherally bound proteins is increased for small liposomes.4.4. Distribution of Bax proteins on liposomes
At all Bax-to-liposome ratios studied by SANS, the protein scat-
tering data contained an intra-vesicular pair interference term (i.e.
a term arising from the presence of several protein scattering
units on the surface of the same liposome), which betrayed the
presence of at least, on average, two independent protein units
(monomer or oligomer) associated with each liposome [44].
According to our membrane targeting assay, under these conditions
(estimated r=12 or larger) each liposome has at least on average
~10–15 Bax proteins and ~2 tBid proteins either inserted in or pe-
ripherally associated with its membrane, forming at least one pore
in at least 50% of the liposomes. In vitro studies of the kinetics of
dye release from liposomes performed with a truncated version of
Bax led to the conclusion that Bax was forming dimers and tetra-
mers in lipid membranes [12]. Our observation that Bax is distribut-
ed over the surface of the liposome is consistent with the presence
of small pores, as observed by Saito et al. for the truncated protein
[12]. It is very likely, however, that the SANS signal detected
comes at least in part from peripherally bound and potentially mo-
nomeric Bax.
Whether the SANS signal detected comes from inserted Bax,
peripherally bound Bax, or both, the observed distribution of Bax on
the membrane of the liposomes is in sharp contrast to that observed
in a previous SANS study for the pore-forming protein pneumolysin
[46]. In the case of pneumolysin, no intra-vesicular pair interference
term was observed, and it was shown that the protein formed a single
toroidal oligomeric structure [46]. Pneumolysin, like α-hemolysin,
belongs to a class of pore-forming proteins (PFPs) known as β-PFPs
whosemembrane insertion domain becomes part of aβ-sheet structure
when inserted in the membrane [79]. Bax, on the other hand, is classi-
ﬁed as an α-PFP along with other proteins, such as the diphtheria
toxin and colicins, forwhich themainmotif of the pore-forming domain
is an α-helical hairpin. In broad terms, whereas β-PFPs tend to form
stable barrel-stave pores with a well-deﬁned stoichiometry, α-PFPs
tend to form unstable toroidal pores with variable stoichiometries.
This difference seems reﬂected here in the distribution of Bax proteins
into several scattering centers distributed over the surface of each lipo-
some, as opposed to the organization of the pneumolysins proteins,
which form one single stable pore. It points to a mechanism of action
of Bax on the membrane that could be global rather than or as well as
local, i.e. where the inﬂuence of Bax on global membrane properties
such as surface tension is at least as important as the local creation or
pores on the membrane.4.5. Effect of Bax insertion in the membrane of liposomes
Membrane thinning and surface area expansion are well documen-
ted consequences of the insertion of antimicrobial peptides into lipid
membranes [80–82] and have also been observed after the insertion
of pneumolysin in liposomal membranes [46], but have yet to be
reported for any full-length Bcl-2 family protein. In the case of antimi-
crobial peptides, a strong body of evidence indicates that membrane
thinning is caused by peptides inserting parallel to the plane of the
membrane, between lipid headgroups, thereby forcing the hydrophobic
chains to reorganize with their carbonyl chains at an angle with the bi-
layer normal. This causes a tension in the membrane which, above a
certain threshold peptide-to-lipid ratio, prevents the insertion of addi-
tional peptides parallel to the membrane and further membrane thin-
ning, and instead promotes the insertion of peptides perpendicular to
the plane of the bilayer and the formation of pores [83]. The observed
threshold peptide-to-lipid ratio for peptide insertion and pore forma-
tion varies from~1:10 to less than 1:200 depending on the peptide [80].
Our observation that the binding of full-length Bax to liposomal
membranes causes membrane thinning suggests that the pore forma-
tion mechanism exhibited by proteins of the Bcl-2 family resembles
that of antimicrobial peptides, i.e. for which the driving force is the
induction of membrane tension through surface thinning. Such amech-
anistic link has already been considered on theoretical grounds [84] and
is supported by previous observations of a structural link between the
pores formed by Bax [14,16,21] or Bax-derived peptides [38], and the
pores formed by antimicrobial peptides – namely that both types of
pores are lipidic. By analogy with the case of pore-forming peptides,
we thus expect that for a threshold value of P/L membrane pores will
form in the membrane of liposomes, and that this threshold value also
corresponds to the P/L at which membrane thinning reaches its limit
value. Strikingly, we did observe that for liposomes of different sizes
pore formation occurs at the same P/L (when a pore formation not re-
lying on surface tension would predict that pore formation would in-
stead occur at a given r), with a threshold value around P/L ~1:2000,
that is at an α-helix-to-lipid ratio around ~1:200, in agreement with
what is observed for pore-forming peptides. Since all the SANS experi-
ments presented here were performed above this threshold value, we
do not expect to observe any further variation in membrane thickness
with Bax concentration. Indeed, the ~10% decrease in membrane thick-
ness that we observe for r ≥ 12 upon interaction with Bax is indepen-
dent of Bax concentration, and is on the order of the maximum
thinning observed for different pore forming peptides above the thresh-
old concentration for pore formation [84]. It is also signiﬁcant to note
that in the conditions of our experiments, tBid (which on its own does
not cause membrane permeabilization) did not cause membrane thin-
ning, reinforcing the idea that membrane thinning is closely linked to
membrane permeabilization.
Membrane deformation by Bax also raises the possibility of long-
range interactions between proteins mediated by the membrane.
Particles inducing either membrane thinning or membrane curvature in-
teract with each other because their relative position can affect the elastic
properties of themembrane [85,86]. The fact that Bax causes strongmem-
brane thinning might help explain the tendency of this protein to homo-
oligomerizewhen inserted in a lipidmembrane, to act as a receptor for it-
self [87], or even to interact with other membrane inserted Bcl-2 family
proteins. It is known that lipid bilayers have a great inﬂuence on pro-
tein–protein interactions between Bcl-2 family members. However, the
mechanism by which the lipids control these interactions remains un-
known [3,88,89]. Our work suggests a possible explanation where these
interactions are in part induced by membrane deformations.
5. Conclusion
The major ﬁndings of this study of Bax interaction with liposomes
are: a) In the presence of excess tBid, Bax binding to 50 nm diameter
400 D. Satsoura et al. / Biochimica et Biophysica Acta 1818 (2012) 384–401liposomes is well described by an equilibrium with an apparent
association constant K ≈ 3 μM−1, resulting at high Bax-to-liposome
ratios in at least 10 Bax molecules per liposome; b) These molecules
are not localized in a single oligomer, but rather are distributed over
the surface of the liposome; c) Most of these Bax molecules are not
fully incorporated into the membrane, but rather protrudes signiﬁcant-
ly from the membrane; d) Bax causes the membrane to thin, an effect
which is accompanied by an increase in liposome radius. Although
well-established for pore-forming peptides, this is the ﬁrst time that
anyone has reportedmembrane thinning for any full length Bcl-2 family
protein.
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